Page 8 - Flipbook
P. 8
The changing landscape
Now things are more complicated
but so much better for patients
PCa treatment paradigm up to 2004
Things were simple but
Depressing when I started
Non- Metastatic mCRPC mCRPC
hormone asymptomatic
metastatic naive symptomatic
Olaparib (post NHT in HRRm)
Lutetium-617
